ISTH Banner

    7pm-10pm CET I 12 July 2026 in Paris, France

    We are pleased to invite you to a scientific dinner organized by Bayer, focusing on recent data from the

    Alfa-PROTECT study
    and from the
    6
    th
    Interim Analysis
    of the
    HEM-POWR study
    . These studies provide data on the safety profile and efficacy of Jivi in patients aged 7 and above, including specific populations of interest.

    Event Disclaimer

    This invitation is

    personal
    and should
    not be distributed
    to other parties.

    This event is intended

    for healthcare providers only.

    This scientific event is provided to an audience of international healthcare professionals from around the world for scientific discussion and scientific exchange.
     

    Prescribing Information Notice

    IMPORTANT
    : Damoctocog alfa pegol prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the product information approved in your home country.

    For any questions on your local prescribing information, please consult directly with Bayer's local affiliate in your country.
    Jivi (Damoctocog alfa pegol) is not available for commercialization in France.

    Data Protection & Additional Resources

    We take your privacy seriously. Your information will be kept confidential and will not be shared with third parties without your consent. Our platform uses industry-standard encryption to protect your data.

    This is page is not monitored to report any Adverse Event (AE) or Product Technical Complaint (PTC). In case you want to report any AE or PTC, please click in the link.